|
Volumn 3, Issue 4, 2005, Pages 256-262
|
Lipid-lowering therapy for elderly patients at risk for coronary events and stroke.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTILIPEMIC AGENT;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
AGED;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIAL;
CORONARY ARTERY DISEASE;
DEMENTIA;
DRUG COMBINATION;
HUMAN;
MIDDLE AGED;
MORTALITY;
PRIMARY PREVENTION;
REVIEW;
AGED;
AGED, 80 AND OVER;
ANTILIPEMIC AGENTS;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIALS;
CORONARY DISEASE;
DEMENTIA;
DRUG THERAPY, COMBINATION;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
MIDDLE AGED;
PRIMARY PREVENTION;
|
EID: 33644878396
PISSN: 15419215
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1541-9215.2005.03549.x Document Type: Review |
Times cited : (9)
|
References (40)
|